News

Chronic Kidney Disease Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working In The Therapeutics Segment Delveinsight
DelveInsight's Chronic Kidney Disease pipeline report depicts a robust space with 75+ active players working to develop 80+ ...
NPPA fixes retail prices for 41 drug combinations, including empagliflozin
NPPA sets retail prices for 41 drug combinations, including 18 variants of off-patent diabetes drug empagliflozin, following steep price drops post-patent expiry ...